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ABSTRACT
DNA double strand breaks are the most cytotoxic
lesions that can occur on the DNA. They can be
repaired by different mechanisms and optimal sur-
vival requires a tight control between them. Here
we uncover protein deneddylation as a major con-
troller of repair pathway choice. Neddylation in-
hibition changes the normal repair profile toward
an increase on homologous recombination. Indeed,
RNF111/UBE2M-mediated neddylation acts as an in-
hibitor of BRCA1 and CtIP-mediated DNA end resec-
tion, a key process in repair pathway choice. By con-
trolling the length of ssDNA produced during DNA
resection, protein neddylation not only affects the
choice between NHEJ and homologous recombina-
tion but also controls the balance between different
recombination subpathways. Thus, protein neddyla-
tion status has a great impact in the way cells re-
spond to DNA breaks.
INTRODUCTION
DNA is constantly challenged by physical and chemical
threats that compromise its structure and function (1).
Those alterations are known as DNA lesions and have to be
eliminated in a process called DNA repair. Faithful restora-
tion of theDNAmolecule ensures that genomes remain sta-
ble enough during the lifetime of an organism to avoid com-
promising viability. To facilitate the repair of DNA, several
molecular machineries have to be coordinated with the rest
of the cellular metabolism. This is particularly true when
repairing DNA molecules in which both strands have been
broken, the so-called DNA double strand breaks (DSBs).
So, upon DSB appearance a complex process known as the
DNAdamage response (DDR) is activated in order to sense
and repair the breaks, but also to coordinate cell cycle pro-
gression, transcription, cellular metabolism, etc. (2,3). The
DDR is a fast response that relies mainly in the alterations
of the profiles of post-translational modifications of many
different proteins, such as phosphorylation, neddylation,
ubiquitylation or sumoylation (2,4).
In strictly DNA repair terms, DSBs can be repaired by a
variety of pathways. Broadly, they can be divided consider-
ing the amount of homology and DNA end processing that
are required during the repair process (5). Non-homologous
end-joining (NHEJ) is the fast and simple religation of two
DNA ends that involve no processing of the break and no
homology (6). However, the ends can be processed through
a mechanism known as DNA end resection, a 5′ to 3′ nucle-
olytic degradation of one strand of the brokenDNAend (5).
Such a process produces single-stranded DNA (ssDNA) 3′
overhang tails. This DNA processing can expose short (3–5
bp long) homologous sequences that can anneal facilitat-
ing the repair in a process called microhomology mediated
end-joining (MMEJ; (7)). Also, DNA end resection is es-
sential for a more complex type of repair of DSBs called
homologous recombination (HR), in which long homolo-
gous sequences are used. There are different subtypes of
HR repair (for review see (8)), depending if the homolo-
gous sequences are in the same molecule and in direct ori-
entation (single strand annealing, SSA); the 3′ overhang is
used to prime a replication that copies the whole chromo-
somal template (break-induced replication, BIR); the newly
synthesized DNA is displaced from the template and rean-
neals to seal the break (synthesis-dependent strand anneal-
ing, SDSA); or a proper Holliday junction is formed (DSB
recombination, DSBR). Thus, a broken DNAmolecule can
basically be repaired by six different repair mechanisms that
have significantly different outcomes (1,5–8): NHEJ is fast,
but the lack of a proofreading activity that ensures that the
two pieces of DNA joint were originally adjacent makes it
a mechanism prone to cause chromosomal rearrangements;
MMEJ shares the same problems as NHEJ, plus it always
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causes deletions at the side of the break; SSA causes the dis-
appearance of one of the repeats and the intervening region;
BIR results in a loss of heterozygosity. SDSA and DSBR
also contribute to chromosomal rearrangements when ho-
mologous sequences different to the sister chromatid are
used. Thus, the regulation between all repair pathways is
essential to minimize genomic instability.
The first control point for DNA repair pathway choice
is the processing of the breaks. DNA end resection inhibits
NHEJ and allows all the other pathways (5). So, DNA end
resection is considered a primary point of DSB repair path-
way choice. In eukaryotes, DNA end resection happens in
two phases: a slow initial phase, catalyzed by the Mre11-
Rad50-Nbs1 (MRN) complex in mammals (5), followed by
a second and fast phase catalyzed by either the exonuclease
Exo1 or the helicase Bloom Syndrome Protein (BLM). To
initiate the process of DNA end resection, a cell cycle acti-
vation step is required in the form of the phosphorylation
of the accessory protein CtIP (9,10).
Protein neddylation consists in the conjugation of the
small peptide NEDD8 to protein lysines (11) in a process
analog to the binding of ubiquitin or SUMO during ubiq-
uitylation and sumoylation, respectively. Neddylation is ac-
complished by the subsequent action of three enzymatic ac-
tivities, E1, E2 and E3 (11). First, the NEDD8 peptide is
conjugated to its E1 (a dimer of UBA1 and NAE1) in an
adenosine triphosphate-dependent manner to form a high-
energy intermediate. Then, NEDD8 is transferred to an
E2 enzyme (either UBE2M or UBE2F). The E2 will con-
jugate next NEDD8 to the target substrate with the help
of an E3. At least three E3 enzymes, RBX1, RBX2 and
RNF111, are involved in protein neddylation (12,13). Fi-
nally, the NEDD8 peptide can be removed from proteins
by the activity of deneddylases. In the cell, there are two
main deneddylases: a large complex known as theCOP9 sig-
nalosome (CSN) and the solo acting enzyme NEDP1 (also
known as SENP8) (14,15). The main substrates of protein
neddylation are a family of proteins known as cullins (16),
but other have been described (13,17–18). As for ubiqui-
tylation and sumoylation, neddylation of cullins and other
proteins have been involved in the DDR (13,17,19–20). Lo-
cal neddylation of proteins at the vicinity of broken DNA
has been shown to happen with a very fast kinetic (13,17).
Moreover, DDR activation seems to be dependent on the
neddylation of several histones and ubiquitin ligases RNF8
and RNF168, both essential for checkpoint activation. In
addition, blocking the neddylation of Cullin 2 leads to a de-
layed DDR (20) and inactivation of Cullin 4 associates with
a defectiveDNA repair (20). As for neddylation, deneddyla-
tion has also been linked with the DDR. Indeed, the COP9
signalosome (CSN) is an ATM substrate (21) and NEDP1
is responsible for elimination of RNF168 neddylation (17).
Despite this relationship, little is known about the impact
of protein neddylation on DNA resection and the choice
between different DSB repair mechanisms.
In order to better characterize the regulatory network
that controls the choice between DSB repair pathways, we
took advantage of our recently published SeeSaw Reporter
(SSR) that measures the balance between NHEJ and HR
(22). Using a collection of small molecule inhibitors, we
discovered that protein neddylation controls the choice be-
tween different repair pathways. We found that such con-
trol is dependent on the NEDD8 E2 UBE2M and E3
RNF111. RNF111/UBE2M-dependent protein neddyla-
tion has been shown to occur rapidly and locally after DNA
damage (13,17). Our data show that such modification in-
hibits CtIP-mediated DNA end resection, suggesting that
a second wave of protein deneddylation is required to acti-
vate HR. Mechanistically, we found that CtIP and its part-
ner BRCA1 constitutively interact with neddylated proteins,
and the overall neddylation status in the cell controls the in-
teraction between them. Finally, we demonstrate that pro-
tein neddylation does not only control the choice between
HR and NHEJ, but also affects the balance between differ-
ent HR subpathways, specially the error-prone SSA. Thus,
neddylation is a key regulatory process in the maintenance
of genomic stability.
MATERIALS AND METHODS
Cell culture, lentiviral infection, transfection and cell survival
U2OS were grown in Dulbecco’s modified Eagle’s medium
(Sigma-Aldrich) supplementedwith 10% fetal bovine serum
(Sigma-Aldrich), 2-mM L-Glutamine (Sigma-Aldrich),
100-units/ml penicillin and 100-g/ml streptomycin
(Sigma-Aldrich) supplemented with 0.5-mg/ml G418
(Gibco). Lentiviral particles were obtained as previously
described (22). Cell survival assays were performed as
described previously (10). Concentration of the different
inhibitors used is shown in Supplementary Table S1.
Information about the shRNA and siRNA used in this
paper can be found in the Supplementary information.
Transfection of HA-NEDD8 (Addgene) was performed
using Fugene HD (Promega), following the manufacturer
instructions.
Gene conversion, SSA, NHEJ and recombination/NHEJ
balance analysis
U2OS cells bearing a single copy integration of the re-
porters DR-GFP (Gene conversion; (23)), SA-GFP (SSA;
(24)), EJ5 (NHEJ; (24)) or SSR (NHEJ/recombination bal-
ance; (22)) were used to analyze the different DSB repair
pathways. In all cases, 4000 cells were plated in 96-well
plates. One day after seeding, they were infected with a
lentivirus harboring an I-SceI and labeled with Blue Flu-
orescent Protein (BFP) (25) using an M.O.I (multiplicity of
infection) of 5. Six hours after infection the same volume of
fresh medium was added. For the SSR screening the small
molecules inhibitors were added at this point (see Supple-
mentary information for concentrations). Cells were grown
during 48 h, fixed with 4% paraformaldehyde, stained with
Hoechst and washed with phosphate buffered saline (PBS)
prior visualization with a fluorescent microscope for blue,
green and, in the case of the SSR, red fluorescence. The re-
pair frequency was calculated as the percentage of blue cells
expressing Green Fluorescent Protein (GFP) for the DR-
GFP (Gene conversion), SA-GFP (SSA), EJ2 (NHEJ) and
EJ5 (MMEJ) reporters. For the HR/NHEJ balance, the ra-
tio between green and red cells in each condition was cal-
culated as published (22). To facilitate the comparison be-
tween experiments, this ratio was normalized with a control
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treated with dimethyl sulfoxide (DMSO). Those conditions
that skew the balance toward an increase inNHEJ repair re-
sult in fold increase below 1. On the contrary, a net increase
of this ratio (values above 1) represents an imbalance of the
SSR toward HR. Data represent a minimum of three sets of
duplicated experiments.
Immunofluorescence microscopy
U2OS cells depleted for CtIP, RNF111 or UBE2M and/or
were treated with MLN4924 or DMSO for 1 h as indi-
cated in each case (see Supplementary Tables S2 and S3 for
siRNAs and shRNAs used in this study). Then, cells were
treated with ionizing radiation (IR; 10 Gy) or mock treated,
incubated 1 h for foci formation and then collected. For
Replication Protein A (RPA) foci, coverslips were treated
for 5 min on ice with pre-extraction buffer (25-mM Hepes,
pH 7.4, 50-mM NaCl, 1-mM ethylenediaminetetraacetic
acid (EDTA), 3-mMMgCl2, 300-mM sucrose and 0.5%Tri-
ton X-100), then fixed with 4% paraformaldehyde (w/v) in
PBS for 15 min. For RIF1 foci the treatment was carried
out at room temperature, the coverslips were fixed with 4%
paraformaldehyde (w/v) in PBS for 15 min, washed three
times with PBS and incubated with PBS+0.25% Triton-
X100 for 15 min. Then, coverslips were washed three times
with PBS and blocked for at least 1 h with 5% fetal bovine
serum (FBS) diluted in PBS. Cells were incubated for 8 h at
4oC with antibodies against RPA32 or RIF1 (see Supple-
mentary information) diluted in 5% FBS in PBS, washed
twice with PBS and then incubated for 1 h at room tem-
perature with the secondary antibody (listed in Supple-
mentary information) diluted in 5% FBS in PBS. Cover-
slips were then washed twice with PBS, mounted with Vec-
tashield mounting medium (Vector Laboratories) contain-
ing 4′,6-diamidino-2-phenylindole (DAPI) and analyzed us-
ing a Nikon NI-E microscope.
RPA foci formation was scored as the percentage of cells
that have RPA foci from the total number of cells. See Sup-
plementary Figure S1 for an example of cells positive and
negative for RPA foci. The number of RIF1 foci per cell was
calculated using the software Metamorph as the number of
dots present in the nucleus (defined by DAPI) on those cells
that show H2AX staining.
Immunoblotting
Extracts were prepared in Laemmli buffer (4% sodium do-
decyl sulphate (SDS), 20% glycerol, 120-mM Tris-HCl, pH
6.8) and proteins were resolved by SDS-polyacrylamide gel
electrophoresis (PAGE) and transferred to Polyvinylidene
fluoride (PVDF; Millipore) followed by immunoblotting.
Western blot analysis was carried out using the antibodies
listed in the Supplementary information. Results were vi-
sualized and quantified using an Odyssey Infrared Imaging
System (Li-Cor).
Immunoprecipitation
U2OS cells were harvested in lysis buffer (50-mM Tris-
HCl, pH 7.4, 100-mM NaCl, 1-mM EDTA, 0.2% de Tri-
ton X-100, 1X protease inhibitors (Roche), 1X phosphatase
inhibitor cocktail 1 (Sigma), NEM 3125 mg/ml (Cal-
biochem)). Protein extract (1 mg) was incubated at 4◦C
with 10l of anti-NEDD8 antibody (for NEDD8 immuno-
precipitation) or with 10 l of a 1:1 combination of two
BRCA1 antibodies (BRCA1 immunoprecipitation; see Sup-
plementary information for details) and with magnetic pro-
tein A Dynabeads (Novex). Beads were then washed three
times with lysis buffer, and the precipitate was eluted in 25
l of Laemmli buffer.
Single molecule analysis of resection tracks
Single molecule analysis of resection tracks (SMART) was
performed as previously described (26). U2OS cells, either
treated with MNL4924 or DMSO, were grown in the pres-
ence of 10-M bromodeoxyuridine (BrdU; GE Health-
care) for 24 h. Cultures were then irradiated (10 Gy), incu-
bated 1 h and then harvested and embedded in low-melting
agarose (Bio-Rad) followed by DNA extraction. To stretch
the DNA fibers, silanized coverslips (Genomic Vision) were
dipped into the DNA solution for 15 min and pulled out
at a constant speed (250 m/s). Coverslips were baked for
2 h at 60◦C and incubated directly without denaturation
with an anti-BrdU mouse monoclonal (Supplementary Ta-
ble S4). After washing with PBS, coverslips were incubated
with the secondary antibody (Supplementary Table S5). Fi-
nally, coverslips were mounted with ProLong R© Gold An-
tifade Reagent (Molecular Probes) and stored at −20◦C.
DNA fibers were observed with Nikon NI-E microscope
and PLANFLOUR40×/0.75 PHLDLL objective. The im-
ages were recorded and processed with NIS ELEMENTS
Nikon software. For each experiment, at least 200 DNA
fiberswere analyzed, and the length ofDNAfiberswasmea-
sured with Adobe Photoshop CS4 Extended version 11.0
(Adobe Systems Incorporated).
Statistical analysis
Statistical significance was determined with a paired t stu-
dent test using the PRISM software (Graphpad Software,
Inc.). Statistically significant difference was labeled with
one, two or three asterisks ifP< 0.05,P< 0.01 orP< 0.001,
respectively. A Mann–Whitney test was used to detect sta-
tistically significant differences between the populations of
resected DNA end detected by SMART.
RESULTS
Screening of small inhibitors that alter the NHEJ/HR ratio
The balance between NHEJ and HR is essential for opti-
mal DNA repair. We have previously designed a reporter to
search for factors that alter such balance (SSR; Figure 1A;
(22)). Briefly, upon creating a DSB using the nuclease I-
SceI, the reporter can be repaired by either NHEJ, render-
ing an active GFP gene, or by a subtype of HR known as
SSA, rendering an active RFP gene. So, the balance be-
tween NHEJ and HR can be calculated as the ratio be-
tween green and red cells. To look for processes that might
affect the choice between DSB repair pathways, we ana-
lyzed the effect of a short list of small molecules in the
SSR system (Figure 1B). As seen in the figure, we found
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Figure 1. Protein neddylation inhibits CtIP-mediated DNA-end resection and HR. (A) Schematic representation of the SeeSaw 2.0 reporter. A GFP
gene is flanked by two truncated parts of RFP gene (RF and FP) sharing 302 bp of homologous sequence. Two I-SceI-target sites were cloned at the
3´end of the GFP gene in opposite orientation. After generation of a DSB by I-SceI expression, the damage may be resolved by NHEJ, thus cells will
express the GFP protein, or using the homologous sequence by HR, creating a functional RFP gene. (B) Effect of different inhibitors in the SSR 2.0. To
measure the deviation from the balance between NHEJ and HR, the ratio between green versus red cells in each conditions was calculated. To facilitate
the comparison between experiments, this ratio was normalized with control cells treated with DMSO. Those conditions that skew the balance toward an
increase NHEJ result in fold increase above 1. On the contrary, a net increase of this ratio (values below 1) represents an imbalance of the SSR toward HR.
Data represent a minimum of three sets of duplicated experiments. (C) DNA-end resection efficiency measured as the percentage of cells positive for RPA
foci. Cells expressing a control shRNA (shScr) or an shRNA against CtIP (shCtIP) were pretreated with 0.2 M of MLN4924 (MLN) or DMSO for 1 h,
then irradiated (10 Gy) and incubated for an additional hour in the presence of the inhibitor. Bars represent the average and standard deviation of three
independent experiments. A representative image of each case is shown. (D) As in (C), but cells transfected with a plasmid bearing an HA-NEDD8 gene
or HA as a control. Asterisk represent statistical significance as described in the Methods section.
that TSA, aphidicolin and the use of the neddylation in-
hibitor MLN4924 skewed the balance toward an increase
in HR. NeitherMirin (aMRE11 inhibitor) nor an inhibitor
of PARP rendered any effect in this reporter system. Such
changes in the SSR ratio do reflect a complex reality in
terms of DSB repair pathway choice. In fact, such obser-
vations might be explained either by an increase in SSA, a
reduction in NHEJ or a combination of both phenomena.
It can even reflect a net increase in both pathways but more
accentuated for SSA or a decrease in both mechanisms but
stronger in NHEJ.
The unbalance toward HR upon neddylation inhibition
was surprising. Neddylation, as sumoylation and ubiquity-
lation, has been reported at the sites of breaks (4,13,17,19).
However, contrary to the increase in HR observed by ned-
dylation inhibition (Figure 1B), we have previously shown
that blocking conjugation of SUMO or ubiquitin skews the
NHEJ/HR balance in the opposite direction (22). Thus, we
decided to analyze in more detail the role of protein neddy-
lation in the choice between DSB repair pathways.
Neddylation controls CtIP-mediated DNA end resection
Considering that cell cycle is a major control point for
DSB repair, we discarded that the effect observed upon
the use of the MLN4924 was due to change in cell cycle
profile (Supplementary Figure S2). Only long treatments
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with MLN4924 changed cell cycle distribution. Thus, we
restricted our experiments to short treatments with the in-
hibitor, unless otherwise specified.
We decided to test if protein neddylation has an impact on
DNA end resection, themajor control point betweenNHEJ
and HR (5). We observed that the preincubation of cells
with MLN4924 increased the number of cells with RPA
foci induced by IR (Figure 1C). Thus, this hyper-resection
phenotype suggested that protein neddylation acts as an in-
hibitor ofDNAend resection. In agreement, overexpression
of NEDD8 rendered the opposite results, i.e. reduced resec-
tion as measured by RPA foci (Figure 1D). As seen in Sup-
plementary Figure S3A, a general increase of protein ned-
dylation is observed in such conditions. Both, the increase in
RPA foci formation and the increase in general protein ned-
dylation are limited. Thus, although in agreement with our
model NEDD8 overexpression skewed the balance toward
a mild increase in NHEJ, it was not statistically significant
(Supplementary Figure S4).
Such an increase in resected DNA observed by neddyla-
tion inhibition was due to a hyperactivation of the canon-
ical pathway, as it disappeared when cells were depleted
of CtIP (Figure 2A; for an example of CtIP depletion see
Supplementary Figure S3B). Indeed, depletion of endoge-
nous CtIP without expressing any other form of CtIP (Fig-
ure 2A, cells transfected with GFP) showed a similar per-
centage of RPA-foci positive cells regardless of the addition
of MLN4924 or the vehicle DMSO. Such effect was clearly
dependent on CtIP as was complemented by the expression
of a GFP-CtIP transgene, which cannot be targeted by the
shRNA (Figure 2A). These data strengthen the idea that
protein neddylation might inhibit HR by controlling CtIP-
mediated resection.
To analyze the impact of the CtIP-mediated hyper-
resection observed upon protein neddylation inhibition, we
tested the viability of cells treated with MLN4924 in cells
depleted of CtIP or control cells. As seen in Figure 2B, and
in agreement with published reports (19), cells were sensi-
tive to chronic treatments with MLN4924 compared with
DMSO-treated cells in the absence of any exogenous DNA
damage. However, if those cells were also depleted of CtIP,
a mild but statistically significant increase in survival was
observed (Figure 2B). Thus, neddylation inhibition toxicity
was partially due to CtIP-dependent hyper-resection of en-
dogenously arousedDNAbreaks.Moreover, CtIP-depleted
cells, but not control cells, were less sensitive to ionizing irra-
diation after a short treatment withMLN4924 (Figure 2C).
Thus, our data suggested that the impairment on DNA re-
section caused by reduction of CtIP levels was partially cor-
rected by the hyper-resection phenotype of neddylation in-
hibition (Figure 2C).
This observation that protein neddylation negatively reg-
ulates CtIP-mediated DNA end resection might explain
why MLN4924 treatment skewed the choice between HR
and NHEJ toward the former. To prove that the unbalance
between HR and NHEJ observed upon neddylation inhibi-
tion was caused by excessive CtIP-mediated resection, we
measured the balance between both repair pathways us-
ing the SSR in cells either mock treated with DMSO or
treated with different doses of MLN4924 in combination
with or without CtIP depletion. As seen in Figure 2D, shC-
tIP depletion prevents the hyper-recombination phenotype
of MLN4924 addition, albeit only partially at higher doses.
CtIP and BRCA1 interaction is controlled by neddylation
In order to understand the molecular mechanism control-
ling the inhibition of DNA end resection through pro-
tein neddylation, we immunoprecipitated neddylated pro-
teins using an anti-NEDD8 antibody. Then, we blotted
for proteins that are important for DNA end resection
and MLN4924 toxicity such as CtIP and BRCA1. Strik-
ingly, we observed that both CtIP and BRCA1 were co-
immunoprecipitatedwith an anti-NEDD8 antibody but not
with a non-related control IgG (Figure 3A). However, when
we blotted the same membranes with an anti-NEDD8 nei-
ther of those protein bands reacted with the antibody (data
not shown). To be sure we were observing an interaction
with neddylated proteins, we repeated the immunoprecip-
itation (IP) upon treatment with MLN4924, and we ob-
served a reduction of the appearance of both CtIP and
BRCA1 (Figure 3B; Anti-NEDD8 IP, and 3C). Thus, we
conclude that neither CtIP nor BRCA1 is neddylated, or
they are neddylated to such a low extent that we could not
detect it. However, both of them separately or as a complex
interact with neddylated proteins. Considering that protein
neddylation is a potent inhibitor of DNA end resection, we
decided to analyze the interaction of CtIP and BRCA1with
neddylated proteins after DNA damage. We observed that
both CtIP and BRCA1 were readily immunoprecipitated
with the NEDD8 antibody in untreated cells, but in both
cases the amount immunoprecipitated was reduced after
DNA damage (Figure 3D and E). CtIP and BRCA1 physi-
cally interact (27) and such interaction facilitates DNA end
resection by eliminatingRIF1 from the sites ofDNAbreaks
(28,29). In fact, we have recently shown that BRCA1 inter-
action with CtIP controls the extent of resection at DSBs
(26). Indeed, when we immunoprecipitated BRCA1, we ob-
served that the amount of co-immunoprecipitated CtIP in-
creased when protein neddylation was inhibited (Figure 3B
and F).More importantly, when neddylation was hampered
a sharp decrease in the number of RIF1 foci per cell af-
ter irradiation was clearly observed (Figure 3G). Support-
ing such results, overexpression of NEDD8 caused a mild,
but statistically significant, increase of the average num-
ber of RIF1 foci per cell (Figure 3H). Thus, our results fit
with the idea that some neddylated protein inhibits CtIP
and BRCA1 interaction and, therefore, reduces DNA end-
resection processivity by hampering the removal of RIF1
from the sites of the break. Moreover, such inhibition is
eliminated by the appearance of DNA damage.
The NEDD8 E2 UBE2M and E3 RNF111 block DNA end
processing
Our data suggest that protein neddylation is a potent in-
hibitor of DNA end processing. Previously it has been
shown that RNF111, an E3 ligase of the STUbL type, is
involved in the DDR by facilitating neddylation and ubiq-
uitylation of several targets (13,30). We analyzed the role
of RNF111 in DNA end resection. As for neddylation in-
hibition with MLN4924 (Figures 1C and 3G), DNA resec-
tion was increased upon depletion of RNF111 as observed
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Figure 2. MLN4924 phenotypes in HR/NHEJ balance and DNA resection depend on CtIP. (A) Cells containing an shRNA against CtIP or a control
shRNA (shScr) were transfected with an shRNA resistant GFP-CtIP fusion. One hour after MLN4924 or DMSO addition, cells were irradiated and an
additional hour later the amount of cells showing RPA foci was scored. Other details are the same as in Figure 1C. (B) Cells expressing an shRNA against
CtIP or control were treated for 12 days with MLN4924 0,1 M or DMSO. The number of colonies formed in the presence of MLN4924 was normalized
with the number of colonies in the DMSO control and plotted. Bars represent the average and standard deviation of three independent experiments.
(C) Cells expressing the indicated shRNAs were irradiated with 2 Gy, with and without 1-h preincubation with 0.2 M of MLN4924 or DMSO, then
incubated 2 h with the inhibitor and then for 12 days in fresh medium. The number of colonies formed normalized with a control not irradiated is shown.
Bars represent the average and standard deviation of three independent experiments. (D) The ratio between HR and NHEJ was calculated with the SSR
system in cells expressing the indicated shRNAs and treated with different doses of MLN4924 as indicated. Details are the same as in (B). Statistical
significance was calculated with a 2-way ANOVA.
by an increase in RPA foci formation (Figure 4A; for an
example of RNF111 depletion see Supplementary Figure
S3C). The same results were observed with two different
siRNA against RNF111 (Figure 4A). This was accompa-
nied by a reduction in RIF1 foci (Figure 4B). As a conse-
quence, and again in a similar way to MLN4924 addition,
the balance between NHEJ and HR was skewed toward an
increase inHRusing the SSR reporter (Figure 4C). In order
to exclude a role of RNF111-mediated ubiquitylation (30)
in those phenotypes, we depleted UBE2M, the E2 enzyme
that collaborates with RNF111 specifically in protein ned-
dylation (13,20). In agreement with the role of RNF111 in
DNA end resection and DSB repair pathway choice being
dependent on its neddylation role, we observed an unbal-
ance of DSB repair pathways toward HR (Figure 4D; see
Supplementary Figure S3D for depletion of UBE2M). Sim-
ilar results were observedwith two different siRNA targeted
against UBE2M. Such unbalance was caused by an in-
crease in RPA foci and a reduction in RIF1 foci (Figure 4E
and F). Thus, our results agree with an inhibitory function
of RNF111/UBE2M-dependent neddylation at the sites of
breaks over CtIP-mediated resection and HR. Indeed, co-
immunoprecipitation of CtIP with BRCA1was increased in
the absence of UBE2M (Figure 4G), suggesting that such a
role occurs, at least partially, at the level of BRCA1–CtIP
interaction.
Protein neddylation regulates DSB repair pathway choice by
affecting the length of resected DNA
Our data suggest that protein neddylation has a major role
controlling DNA end resection, hence controlling the ap-
pearance of ssDNA. Thus, it might regulate DSB repair
pathway choice. To analyze this idea, we tested different
DSB repair pathways upon protein neddylation inhibition
withMLN4924. First, we used the previously publishedEJ5
reporter (24) to analyze NHEJ. In this reporter, an active
GFP gene is formed when cells repair an I-SceI-induced
DSB. As expected, NHEJ was inhibited due to an increase
in DNA end resection (Figure 5A). The hyper-resection we
observed by an increase on RPA foci can be due to two, not
mutually exclusive, scenarios: an increase in the number of
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Figure 3. CtIP and BRCA1 complex formation is controlled by their interaction with neddylated proteins. (A) CtIP and BRCA interact with neddylated
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breaks that are resected (for example due to resection taken
place in G1) and/or an increase in the length of resected
DNA. Whereas in the first case all homology-driven DNA-
repair mechanisms will be favored, in the second case hyper-
resection will stimulate those pathways that require longer
resection, such SSA, but would block some HR subpath-
ways if resection reaches outside the homologous stretch
of DNA (see the Discussion section for details; Figure 6B).
Thus, we tested different HR pathways. As the SSR system
used to initiate this study compares NHEJ with SSA, we
first used the SA-GFP reporter that measures SSA (24). As
expected, we observed that neddylation inhibition increases
this particular repair pathway (Figure 5B). This increase
in SSA and reduction in NHEJ explain the unbalance ob-
served with MLN4924 addition with the SSR. Strikingly,
not all HR subpathways were affected equally by neddy-
lation inhibition. Indeed, gene conversion was diminished
when the DR-GFP reporter (23) was used (Figure 5C).
Hence, we hypothesized that neddylation is controlling the
extent of resection and not the amount of breaks that are re-
sected, favoring SSA over other HR subpathways. To prove
it, we performed a SMART assay, that measures the length
of resected DNA at the level of individual fibers (26), with
cells treated with MLN4924 or DMSO. Although resec-
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tion is an asynchronous process in the population, thus the
length of resected DNA is heterogeneous, we observed that
treatment with MLN4924 statistically changes the shape of
the population (Figure 5D), and resected DNA tracks tend
to be longer. In fact, we observed that neddylation inhibi-
tion causes a 20% increase in the median length of resected
DNA (Figure 5E). Thus we conclude that protein neddy-
lation controls the extent of resection and impacts in the
repair mechanism that will be used to repair the break, but
not only at the decision between NHEJ and HR but also
at the choice between different homology-mediated repair
pathways.
DISCUSSION
Here, we have tested several small molecule inhibitors used
in clinical trials and related with the DDR for their im-
pact in the choice between NHEJ and HR. We observed
that protein deacetylation has a great impact in repair path-
way choice (Figure 1B). TSA skewed the balance toward
HR. Affecting NHEJ, HR or both, something we could
not discriminate with this genetic tool, could cause this un-
balance. TSA inhibits specifically class I and II HDACs,
such as HDAC1 and HDAC2, both of them previously re-
lated with DNA repair (31). Moreover, TSA has been pre-
viously shown to alter chromatin structure in a way that fa-
cilitates ATR activation (32). Thus, we propose that TSA
effect on DSB repair pathway choice might be due to this
altered chromatin structure that facilitates DNA end resec-
tion, hence increasing SSA and reducing NHEJ.
Another small molecule that alters the relative ratio be-
tween HR and NHEJ was the replication inhibitor aphidi-
colin (Figure 1B). Aphidicolin inhibits the DNA poly-
merase and, as a consequence, cells accumulate in S-phase.
In agreement with HR being restricted to S and G2 phases
of the cell cycle (5), such accumulation in S-phase renders a
net increase of HR over NHEJ, as shown in Figure 1B.
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Figure 5. Effect of inhibition of protein neddylation in different DSB repair pathways. (A) In the EJ5 reporter (left), I-SceI-induced DSB can be repaired
by NHEJ recreating an active GFP gene, containing or not a functional I-SceI target site. The percentage of green cells was calculated as described in
the Materials and Methods section in cells pretreated with MLN4924 or DMSO. This percentage was normalized with the DMSO-treated cells value and
plotted. Bars represent the average and standard deviation of three independent experiments. (B) Same as (A), but using the SA-GFP. Such a reporter is
formed by two truncated copies of the GFP that, upon SSA, can restore an active GFP gene with the deletion of one of the repeats and the intervening
region. Other details are the same as in (A). (C) The DR-GFP reporter is formed by two non-functional copies of the GFP. Gene conversion induced by
an I-SceI-mediated DSB restores an active GFP gene. The efficiency of gene conversion was calculated as described in (A) for NHEJ. (D) Single molecule
analysis of resection tracks (SMART) of cells treated with DMSO or MLN4924. The length of individual fibers is shown as a scatter plot. A Mann–
Whitney test was performed to analyze the statistical difference of both populations. (E) The median length of resected DNA was normalized to DMSO.
The average of four independent experiments is shown.
We also tested an inhibitor of PARP due to its established
relationship with DSB repair. PARP1 inhibition blocks sin-
gle strand break repair. Those unrepaired breaks are car-
ried out to the next S-phase where they are converted to
DSBs, and HR has been proved essential to repair them
(33). Moreover, PARP1 and PARP2 have been directly in-
volved in NHEJ and HR choice (2). In addition, the newest
member of the PARP family, PARP3, plays a role in DNA
repair by HR and it has been shown to control DNA end
resection (34). However, when we used a dose of PARP in-
hibitor that reduces the activity of all three PARP proteins,
we did not see any effect in the SSR system. This might be
due to a complex crosstalk between positive and negative
effect of different PARP proteins in repair pathway choice.
Previously, others and we have shown that MRE11 is a
major regulator of DSB repair pathway, probably due to its
role in DNA end resection (2,5,22,35). MRE11 has differ-
ent catalytic activities, such as 3′-5′ and 5′-3′ exonuclease
and endonuclease. We usedMirin, a known inhibitor of the
exonucleolytic activity of MRE11 (36). As there is no effect
of Mirin on the SSR, we conclude that the exonuclease ac-
tivity of Mre11 is not required for DNA end processing, in
agreement with other reports that propose that resection by
the MRN complex is based on the release of short ssDNA
oligos produced by Mre11 endonuclease activity (35,37).
Ubiquitylation and sumoylation of proteins have a ma-
jor role in the DDR and DSB repair (4) and we have
shown that they mainly facilitate HR to take place (22).
So, we tested the effect of another ubiquitin-like protein
modifier, NEDD8, in DSB pathway choice. For that we
used a neddylation inhibitor MLN4924 (38) and observed
that exerted an effect similar to TSA (Figure 1B). Namely,
neddylation inhibition, and contrary to blocking conjuga-
tion of Ubiquitin and SUMO (22), skewed the balance to-
ward homology-mediated repair. Indeed, protein neddyla-
tion seems to be a potent inhibitor of DNA-end resec-
tion and HR. In agreement with our results, impairment
of neddylation by MLN4924 treatment or depletion of the
NEDD8 E2 ligase UBE2M has been shown to increase
RAD51 foci (20). There have been some reports involving
protein neddylation in the DDR (13,17,19–20). All of them
showed a role of protein neddylation at the sites of breaks
(13,17). Different histones (H2A, H4) and DDR-related
Ubiquitin ligases (RNF8, RNF168) seem to be neddylated
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and such neddylation is required for proper DDR activa-
tion. Moreover, neddylation of specific cullins also impacts
on the response toDNAdamage (20). Our data suggest that
one or several unknown proteins neddylated in a UBE2M-
dependent manner limit the length of resected DNA by
blocking the interaction between CtIP and BRCA1 (Fig-
ures 3 and 4G), effectively hampering RIF1 removal from
damaged chromatin (Figure 3). This hypothesis agrees with
the idea that CtIP–BRCA1 interaction modulates the ex-
tent and rate of DNA-end resection (26). We have not been
able to observe neddylation of either CtIP or BRCA1, thus
we propose that some unknown factor is affecting their in-
teraction when is conjugated to NEDD8. One likely candi-
date is RNF168 that is known to be neddylated (17); its re-
cruitment to damaged DNA is neddylation dependent (13)
and controls BRCA1 retention at sites of DSBs (39). How-
ever, we cannot discard the contribution of other neddy-
lated factors, including Cullins. Indeed, a relationship be-
tween CUL7 and CtIP has been recently shown in terms of
pathology, as specificmutations in either gene are associated
with primordial dwarfism with similar phenotypes (40,41).
Although our data support that neddylation inhibits CtIP-
mediated resection, we cannot discard that some of the ob-
served phenotypes depend also on putative roles of ned-
dylation in other steps of HR, such as the BLM/EXO1-
dependent long-range resection, the strand annealing reac-
tion, etc.
Previously reported neddylation at the sites of damaged
DNA is dependent on the activity of RNF111 (13,17).
RNF111 activity increases upon DNA damage and acts lo-
cally in the vicinity of the breaks. RNF111 andNEDD8 are
recruited fast to the sites of breaks, with a peak at 10 min
after DNA damage induction (13). After that, its accumu-
lation fades slowly with time. Thus, local protein neddyla-
tion is indeed a quick response that fits with a role with a
fast DNA repair such as NHEJ. Although we cannot ex-
clude a role of the ubiquitylation function of RNF111 in
the phenotypes observed, the fact that similar effects are
observed with UBE2M depletion leads us to propose that
the neddylation activity of RNF111/UBE2M is involved in
DNA resection, hence HR, locally (Figure 4). Qualitatively
RNF111 and UBE2M depletion showed similar pheno-
types (Figure 4), but the differences inmagnitudemight sug-
gest that both RNF111 and UBE2M have additional and
independent roles controlling DNA end resection, some-
thing we cannot discard. In agreement with the general ned-
dylation status controlling DNA end processing, overex-
pression of NEDD8 by itself reduces DNA end resection
(Figure 1D). So, we propose that protein neddylation might
regulate DSB repair acting as a molecular timer (Figure
6A). Early after DSB appearance, RNF111 accumulation
would hamper DNA end resection favoring NHEJ. Later,
neddylated proteins will lose NEDD8 due to passive and
active mechanisms. On the one hand, RNF111 will be ex-
cluded from damaged chromatin (13). On the other hand,
the action of the CSN complex and NEDP1 might actively
contribute to protein deneddylation. In agreement with this
model, it has been shown that both deneddylase activities
are activated as a response to DNA damage. First, two sub-
units of the main deneddylase activity, the COP9 signalo-
some (CSN), are known to be an ATM substrate (21). Also,
RNF168 is first neddylated after DNA damage, but this
neddylation is transient and starts to drop after 30 min due
to the action of the dennedylase NEDP1 (17).
This neddylation-dependent molecular timer will regu-
late the type of DSB repair that will take place by control-
ling the extent of DNA end resection (Figures 5D and 6).
This agrees with neddylation modulating CtIP–BRCA1 in-
teraction that we have shown controls the length of resected
DNA (26). First, the accumulation of RNF111-mediated
neddylationwill favor classical NHEJ. Some of those breaks
will not be suitable for NHEJ, probably due to modifica-
tion of the DNA ends and will remain unrepaired longer.
As soon as protein neddylation starts to disappear, prob-
ably by both RNF111 eviction and CSN and NEDP1 ac-
tivation, some resection of the break will take place. This
limited processing will ‘clean’ the DNA ends and might ac-
tivate short trackMMEJ. Even then some breaksmight stay
unrepaired. Further protein deneddylation of proteins will
facilitate CtIP and BRCA1 interaction, increasing resection
processivity by facilitating RIF1 removal and the length of
resected DNA. The exposed ssDNAwill be engaged in HR.
During recombination with an ectopic sequence, as in the
recombination measured by the DR-GFP reporter, it is es-
sential that resection is limited within the homolog region
(Figure 6B). Only then, non-mutagenic subtypes of recom-
bination such as DSBR and SDSA can take place (Figure
6B, a–g). However, in the complete absence of protein ned-
dylation, as with MLN4924 treatment, hyper-resection will
occur, i.e. resectedDNAwill be longer (Figure 6B, h). Then,
both DSBR and SDSA are effectively blocked (Figure 6B,
i–k). This explains our observation that short track gene
conversion with the DR-GFP reporter is reduced upon in-
hibition of protein neddylation (Figure 5C). In agreement,
RNF111 and UBE2M depletion have also been shown to
reduce gene conversion on the DR-GFP reporter despite
the later increasing RAD51 foci formation (13,20). Thus,
hyper-resection caused by lack of protein neddylation will
reduce not onlyNHEJbut also short-track gene conversion,
and will switch the repair profile toward pathways that are
favored by long resected tracks such as SSA (Figure 6B, l).
Additionally, BIR might happen independently of the ex-
tent of resected DNA (Figure 6B, d and m). In any case,
hyper-resection favors mutagenic recombination pathways
and might potentially lead to deletions or loss of heterozy-
gosis.
In principle, this limitation in the extent of resected DNA
required for gene conversion will not apply to recombina-
tion with the sister chromatid, as the donor and acceptor
molecules are completely identical. However, even in this
case hyper-resection will reduce the chances of the newly
synthesized DNA to catch up with the resected 5′ end to
form an HJ (42). Moreover, it will increase the probability
of uncovering repeated sequences that can be the substrate
for an SSA-type of recombination. Thus, complete dened-
dylation, such as the one obtained with MLN4924 addi-
tion, albeit not completely blocking gene-conversion when
the sister chromatid is used as a template, will facilitate the
mutagenic SSA subpathway even in this condition. Hence,
we propose that protein neddylation controls DSB repair
pathway choice, the decision not only between NHEJ and
HR but also between different recombination subpathways.
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Accordingly with previous results and our observations, we
propose that a wave of protein neddylation and deneddy-
lation controls the timing of DNA end resection, thus es-
tablishing a temporal organization between different repair
types.
This relationship between protein neddylation and DSB
repair can explain the potent anticancer activity showed
by MLN4924 in pre-clinical studies (38). Moreover, con-
sidering that HR is defective in many human tumors, it is
worth to speculate that MLN4924 will be especially suc-
cessful in treating those cancers. In them, MLN4924 will
channel endogenous DNA breaks toward the impaired HR
repair. Thus, we speculate that HR-deficient tumors might
be hypersensitive to MLN4924. However, this will apply
only to those cancer cells defective in HR steps that take
place after DNA end resection. On the contrary, our data
suggest that cells impaired in DNA end resection, such
as depleted for CtIP, are resistant to MLN4924 treatment
(Figure 2B). Interestingly, a reduction of MLN4924 toxic-
ity has also been observed when other proteins involved in
DNA end resection such as BLM or BRCA1 are depleted
(43,44). In addition, our data suggest that in resection-
deficient backgrounds MLN4924 protects cells from irradi-
ation (Figure 2C). Thus, we postulate that MLN4924 treat-
ment in tumors with reduced amounts of resection proteins
such as CtIP and BRCA1will reduce the efficiency of radio-
therapy. As both proteins are known to be downregulated in
certain tumors (45,46), it will be important to know the ge-
netic contribution of different recombination genes to spe-
cific tumors to evaluate the potential effect of MLN4924 as
an anticancer drug.
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